Advertisement

Pharmacy World & Science

, Volume 30, Issue 5, pp 605–609 | Cite as

Repeat prescribing in primary care: a prescription study

  • Leena SaastamoinenEmail author
  • Hannes Enlund
  • Timo Klaukka
Short Research Report

Abstract

Objective There is limited knowledge on repeat prescribing of different drug groups in cases where the physician does not see the patient. This study aimed to investigate the frequency of repeat prescribing of different drug groups both with and without consultation. Method The study was a nationwide prescription database study performed in Finnish primary care in 2001. Each physician in a sample of 400 physicians was asked to report all patient contacts over a specified period of five consecutive working days once over a period of six months, and another sample of 400 physicians did the same for the next six months. Copies of physicians’ prescriptions were collected and data on the drugs and type of prescriptions were recorded. Repeat prescriptions issued with and without a consultation were included. ResultsAbout 19% of all prescriptions were issued without direct contact between the physician and the patient. In the different drug groups, the range was from 2% of antibiotics to 57% of antipsychotics. Psychotropics including hypnotics and tranquillizers, cardiovascular drugs and drugs for elderly patients were most often issued without consultation. Conclusion Repeat prescribing without consultation is common especially for elderly patients and users of psychotropics and cardiovascular drugs, and this may contribute to suboptimal therapy.

Keywords

Finland GP’s Prescriptions Physicians Primary care Repeat prescribing 

Notes

Acknowledgment

The authors wish to thank Suomen IMS Health OY for their support.

Funding

The Elli Turunen Fund of the Finnish Cultural Foundation.

Conflicts of interest

We declare that we have no conflict of interest.

References

  1. 1.
    Harris CM, Dajda R. The scale of repeat prescribing. Br J Gen Pract. 1996;46:649–53.PubMedGoogle Scholar
  2. 2.
    Zermansky A. Who controls repeats? Br J Gen Pract. 1996;46:643–7.PubMedGoogle Scholar
  3. 3.
    McGavock H, Wilson-Davis K, Connolly JP. Repeat prescribing management–a cause for concern? Br J Gen Pract. 1999;49:343–7.PubMedGoogle Scholar
  4. 4.
    Connolly J, McGavock H. Repeat prescribing: which diagnoses, which drugs? Pharmacoepidemiol Drug Saf. 2000;9:305–11.CrossRefGoogle Scholar
  5. 5.
    Jones J, Matheson C, Bond C. Patient satisfaction with a community pharmacist-managed system of repeat prescribing. Int J Pharm Pract. 2000;8:291–7.Google Scholar
  6. 6.
    Dijkers FW. Repeat prescriptions: a study in general practice in the Netherlands. Dissertation, Faculty of Medical Science, University of Groningen, Groningen 1997.Google Scholar
  7. 7.
    Saastamoinen L, Enlund H, Klaukka T. Repeat prescribing processes in primary care: a qualitative study. Int J Pharm Pract. 2008;16:155–7.CrossRefGoogle Scholar
  8. 8.
    Rokstad K, Straand J. Drug prescribing during direct and indirect contacts with patients in general practice. A report from the More & Romsdal Prescription Study. Scand J Prim Health Care. 1997;15:103–8.Google Scholar
  9. 9.
    Finnish Statistics on Medicines 2006. National Agency for Medicines and Social Insurance Institution. Helsinki; 2007.Google Scholar
  10. 10.
    Avohoidon lääkärikäynnit ja lääkärin potilaat ikäryhmittäin. From the Internet 21st January 2008: http://www.stakes.fi/FI/tilastot/aiheittain/Terveyspalvelut/yleisterveydenhuolto/YleisterveydenhuoltoTkAvohoito.htm.
  11. 11.
    Finnish Statistics on Medicines 2001. National Agency for Medicines and Social Insurance Institution. Helsinki; 2002.Google Scholar
  12. 12.
    IMS Global Insights. 2008. From the Internet 17th January 2008: http://www.imshealth.com/web/home/0,3153,64576068_63872702,00.html.
  13. 13.
    Strom B. Other approaches to pharmacoepidemiology studies. Pages 349–362 In: Strom B, editor. Pharmacoepidemiology, 4th ed. USA: Wiley; 2007.Google Scholar
  14. 14.
    Straand J, Sandvik H. Stopping long-term drug therapy in general practice. How well do physicians and patients agree? Fam Pract. 2001;18:597–601.PubMedCrossRefGoogle Scholar
  15. 16.
    Curran HV, Collins R, Fletcher S, Kee SCY, Woods B, Iliffe S. Older adults and withdraval from benzodiazepine hypnotics in general practice: effects on cognitive function, sleep, mood and quality of life. Psychol Med. 2003;33:1223–37.PubMedCrossRefGoogle Scholar
  16. 16.
    He J, Muntner P, Chen J, Roccella E, Streiffer R, Whelton P. Factors associated with hypertension control in the general population of the United States. Arch Intern Med. 2002;162:1051–8.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2008

Authors and Affiliations

  • Leena Saastamoinen
    • 1
    Email author
  • Hannes Enlund
    • 2
    • 3
  • Timo Klaukka
    • 1
  1. 1.The Social Insurance InstitutionHelsinkiFinland
  2. 2.Department of Social PharmacyUniversity of KuopioKuopioFinland
  3. 3.Department of Pharmacy Practice, Faculty of PharmacyKuwait UniversityKuwait CityKuwait

Personalised recommendations